Corcept Therapeutics said on Monday its experimental drug in combination with chemotherapy helped delay progression of a type ...

This year, researchers Megan Shen, PhD, and Mary L. “Nora” Disis, MD, of Fred Hutch Cancer Center and UW Medicine ...

A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer.

Polycistic ovary syndrome is a hormonal disorder causing enlarged ovaries with small cysts on the outer edges. In a new interview, Meghann told Stylist: 'For years I tried a lot of different ...

Inside the Reproductive Sciences Lab at the University of Colorado Anschutz Medical Campus in Aurora, researchers are on the ...

Chemotherapy regimens chosen by the ChemoID assay dramatically increased ORR in patients with platinum-resistant ovarian ...

The ultrasound came back clear, but the CT scan, which not all doctors order, revealed an advanced form of cancer. Not the type, at that stage, just confirmation that whatever it was had spread. It ...

The phase 3 trial showed relacorilant with chemotherapy improved progression-free and overall survival in platinum-resistant ...

A new study has identified the protein ADAMTS5 as playing a crucial role in the spread of ovarian cancer cells, offering a ...

The large, randomized phase 3 study revealed a 30% reduction in risk of disease progression in patients with platinum-resistant ovarian cancer, compared to those just treated with nab-paclitaxel.

Berberine is a powder made from different plants. It has many benefits, including improving blood sugar levels, reducing ...